| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
19.05 |
uV |
3.75 |
9.92 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108550 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
159.83 |
uV |
21.35 |
56.49 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108558 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
31.22 |
uV |
8.16 |
21.59 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108551 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
179.49 |
uV |
20.75 |
54.9 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108559 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
94.13 |
uV |
15.33 |
40.56 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108556 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
3.13 |
uV |
1.81 |
4.79 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108548 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
24.79 |
uV |
7.82 |
20.69 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108552 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
31.96 |
uV |
9.73 |
25.74 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108553 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
10.28 |
uV |
1.69 |
4.47 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108554 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
32.75 |
uV |
13.42 |
35.51 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108555 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
131.7 |
uV |
16.13 |
42.68 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108557 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
15.31 |
uV |
2.98 |
7.88 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108549 |
3123 |